Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co KGaA    FRE   DE0005785604

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Fresenius Sets Pricing On EUR500 Million 7-Year Bond At 4.25% Area

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/21/2012 | 01:24pm CET

("Fresenius Sets Pricing On EUR500M 7-Year Bond At 4.25% Area," at 1020 GMT, misstated the vehicle issuing the bond in the first paragraph. The correct version follows:)

-German medical care company Fresenius SE & CO. KGaA (>> Fresenius SE & Co KGaA) has set price guidance on its EUR500 million seven-year bond in the area of 4.25%, one of the banks on the deal said Wednesday.

The issue will be priced later Wednesday, and books on the deal are comfortably oversubscribed, said one of the banks on the deal. The issue was primarily targeted at retail accounts, which showed a good deal of interest, it added.

The bond will be used--among other corporate purposes--to fund the acquisition of hospital operator Damp Group, which Fresenius acquired in October 2011.

Expected ratings are Ba1 from Moody's Investors Service and BB+ from Standard & Poor's Corp. and Fitch Ratings.

Royal Bank of Scotland Group PLC, Deutsche Bank AG, Commerzbank AG, LBBW and Bayern LB are lead managers on the deal.

-By Serena Ruffoni, Dow Jones Newswires; +44 (0) 207 842 9349; serena.ruffoni@dowjones.com

Stocks mentioned in the article : Fresenius SE & Co KGaA
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS SE & CO KGAA
12:48a FRESENIUS : Pelham Police Department assessed by national accreditation commissi..
12/08 TUNISIE-TEXTILE : La STB Invest vote contre des résolutions de la Sitex
12/01 FRESENIUS : will focus on IFRS reporting starting fiscal year 2017
11/29 FRESENIUS : Court halts construction of new Medical Center
11/25 FRESENIUS : Accreditation commission to hold public forum for Anniston Police De..
11/21 FRESENIUS : SU Police Department Earns CALEA Reaccreditation
11/18 FRESENIUS : Enfield Police Department Receives Advanced CALEA Accreditation With..
11/17 FRESENIUS : Police and Public Safety Department Earns International Accreditatio..
11/13 FRESENIUS : CPD receives accreditation for excellence
11/04 DGAP-DD : Fresenius SE & Co. KGaA deutsch
More news
Sector news : Hospitals, Clinics & Primary Care Services
12/05 CAMBIAN : UK health firm Cambian to sell adult services unit for 377 mln stg
11/24DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare 3Q Net Profit Up 46%
11/18 Synlab ready to snap up more lab chains after debt deal
11/16 South Africa's Life Healthcare to buy controlling stake in Britain's Alliance..
11/09 Pharma, biotech shares soar as Trump win calms pricing talk
More sector news : Hospitals, Clinics & Primary Care Services
News from SeekingAlpha
10/30 Fresenius' (FSNUY) CEO Stephan Sturm on Q3 2016 Results - Earnings Call Trans..
10/27 Fresenius SE & Co reports Q3 results
09/20 A Unique Method To Value Dividend Stocks Based On Expected Growth
08/07 Fresenius SE & Co. KGaA ADR 2016 Q2 - Results - Earnings Call Slides
08/07 Fresenius' Cempra's (FSNUY) CEO Stephan Sturm on Q2 2016 Results - Earnings C..
Advertisement
Financials (€)
Sales 2016 29 193 M
EBIT 2016 4 347 M
Net income 2016 1 611 M
Debt 2016 14 111 M
Yield 2016 0,91%
P/E ratio 2016 23,43
P/E ratio 2017 20,30
EV / Sales 2016 1,77x
EV / Sales 2017 1,58x
Capitalization 37 500 M
More Financials
Chart FRESENIUS SE & CO KGAA
Duration : Period :
Fresenius SE & Co KGaA Technical Analysis Chart | FRE | DE0005785604 | 4-Traders
Full-screen chart
Technical analysis trends FRESENIUS SE & CO...
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 78,1 €
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stephan Sturm Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Niko Stumpfögger Member-Supervisory Board
Dario Anselmo Ilossi Member-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FRESENIUS SE & CO KGAA3.93%39 804
IHH HEALTHCARE BHD--.--%11 925
RAMSAY HEALTH CARE LIM..0.15%10 345
BANGKOK DUSIT MEDICAL ..--.--%9 965
MEDICLINIC INTERNATION..-11.59%6 537
AIER EYE HOSPITAL GROU..--.--%4 950
More Results